Modulation of IAPs for the treatment of proliferative diseases
US6133437A · kind A · utility
33Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 1997 |
| Grant date | Oct 17, 2000 |
| Priority date | — |
| Expiry date | Feb 13, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/136
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are diagnostic and prognostic kits for the detection and treatment of proliferative diseases such as ovarian cancer, breast cancer, and lymphoma. Also disclosed are cancer therapeutics utilizing IAP antisense nucleic acids IAP fragments, and antibodies which specifically bind IAP polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.